Oak Thistle LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
69,383
+52,467
+310% +$2.85M 0.29% 116
2026
Q1
$1.06M Buy
+16,916
New +$1.35M 0.1% 326
2025
Q4
Sell
-48,501
Closed -$4.74M 511
2025
Q3
$4.74M Buy
+48,501
New +$5.02M 0.72% 8
2025
Q2
Sell
-7,359
Closed -$742K 472
2025
Q1
$742K Buy
+7,359
New +$741K 0.15% 242
2023
Q3
Sell
-7,962
Closed -$431K 470
2023
Q2
$431K Buy
+7,962
New +$416K 0.23% 189
2022
Q1
Sell
-5,698
Closed -$242K 387
2021
Q4
$242K Buy
+5,698
New +$239K 0.19% 245

Other funds holding BSX

Oak Thistle LLC's BSX Position: Q2 2026 in Review

Oak Thistle LLC increased its Boston Scientific (BSX) stake by 310% in Q2 2026, buying an estimated $2.85M and bringing the position to 69,383 shares worth $2.96M. The position accounts for 0.29% of the portfolio, ranked #116.

Oak Thistle LLC first reported a position in BSX in Q4 2021 and has held it in 6 quarters since. The position peaked at $4.74M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Oak Thistle LLC held 69,383 shares of Boston Scientific worth $2.96M as of Q2 2026.
  • Oak Thistle LLC bought 52,467 Boston Scientific shares in Q2 2026, an estimated $2.85M.
  • Boston Scientific made up 0.29% of Oak Thistle LLC's portfolio in Q2 2026, its #116 holding.
  • Oak Thistle LLC first reported a position in Boston Scientific in Q4 2021 and has held it in 6 quarters since.
  • Oak Thistle LLC's Boston Scientific position peaked at $4.74M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.